Literature DB >> 16554247

Infections and thalassaemia.

Sandro Vento1, Francesca Cainelli, Francesco Cesario.   

Abstract

Infections are major complications and constitute the second most common cause of mortality and a main cause of morbidity in patients with thalassaemia, a group of genetic disorders of haemoglobin synthesis characterised by a disturbance of globin chain production. Thalassaemias are among the most common genetic disorders in the world. Predisposing factors for infections in thalassaemic patients include severe anaemia, iron overload, splenectomy, and a range of immune abnormalities. Major causative organisms of bacterial infections in thalassaemic patients are Klebsiella spp in Asia and Yersinia enterocolitica in western countries. Transfusion-associated viral infections (especially hepatitis C) can lead to liver cirrhosis and hepatocellular carcinoma. A unique and challenging infection detected in Asian patients is pythiosis, caused by a fungus-like organism, the mortality rate of which is very high. Because the prognosis for thalassaemia has much improved, with many patients surviving to the fifth decade of life in developed countries, it is mandatory to reduce mortality by recognising and presumptively treating infections in these patients as quickly as possible.

Entities:  

Mesh:

Year:  2006        PMID: 16554247     DOI: 10.1016/S1473-3099(06)70437-6

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  41 in total

1.  Hepcidin Protects against Lethal Escherichia coli Sepsis in Mice Inoculated with Isolates from Septic Patients.

Authors:  Deborah Stefanova; Antoan Raychev; Jaime Deville; Romney Humphries; Shelley Campeau; Piotr Ruchala; Elizabeta Nemeth; Tomas Ganz; Yonca Bulut
Journal:  Infect Immun       Date:  2018-06-21       Impact factor: 3.441

2.  Iron overload correlates with serum liver fibrotic markers and liver dysfunction: Potential new methods to predict iron overload-related liver fibrosis in thalassemia patients.

Authors:  Man Wang; Rongrong Liu; Yuzhen Liang; Gaohui Yang; Yumei Huang; Chunlan Yu; Kaiqi Sun; Yongrong Lai; Yang Xia
Journal:  United European Gastroenterol J       Date:  2016-06-23       Impact factor: 4.623

3.  Iron, haemochromatosis and thalassaemia as risk factors for fibrosis in hepatitis C virus infection.

Authors:  Mark Thursz
Journal:  Gut       Date:  2007-05       Impact factor: 23.059

Review 4.  2017 KASL clinical practice guidelines management of hepatitis C: Treatment of chronic hepatitis C.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2018-08-10

Review 5.  Iron and infection.

Authors:  Tomas Ganz
Journal:  Int J Hematol       Date:  2017-11-16       Impact factor: 2.490

Review 6.  KASL clinical practice guidelines: management of hepatitis C.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2016-03-28

Review 7.  Current Standards of Care and Long Term Outcomes for Thalassemia and Sickle Cell Disease.

Authors:  Satheesh Chonat; Charles T Quinn
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

8.  Clinical spectrum of serious bacterial infections among splenectomized patients with hemoglobinopathies in Israel: a 37-year follow-up study.

Authors:  W Sakran; C Levin; Y Kenes; R Colodner; A Koren
Journal:  Infection       Date:  2011-08-25       Impact factor: 3.553

Review 9.  Iron metabolism in children: confounding factors.

Authors:  Gary M Brittenham
Journal:  Food Nutr Bull       Date:  2007-12       Impact factor: 2.069

10.  High frequency of SEN virus infection in thalassemic patients and healthy blood donors in Iran.

Authors:  Abbas Karimi-Rastehkenari; Majid Bouzari
Journal:  Virol J       Date:  2010-01-02       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.